133 related articles for article (PubMed ID: 38517352)
21. Hexahydropyrrolo[2,3-
Doens D; Valdés-Tresanco ME; Vasquez V; Carreira MB; De La Guardia Y; Stephens DE; Nguyen VD; Nguyen VT; Gu J; Hegde ML; Larionov OV; Valiente PA; Lleonart R; Fernández PL
ACS Chem Neurosci; 2019 Oct; 10(10):4250-4263. PubMed ID: 31545596
[TBL] [Abstract][Full Text] [Related]
22. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents.
Li B; Huang AL; Zhang YL; Li Z; Ding HW; Huang C; Meng XM; Li J
Molecules; 2017 Jun; 22(7):. PubMed ID: 28672874
[TBL] [Abstract][Full Text] [Related]
24. Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study.
Zou Y; Qian Z; Chen Y; Qian H; Wei G; Zhang Q
ACS Chem Neurosci; 2019 Mar; 10(3):1585-1594. PubMed ID: 30605312
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?
Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT
J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281
[TBL] [Abstract][Full Text] [Related]
26. In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process.
Hernández-Rodríguez M; Correa-Basurto J; Benitez-Cardoza CG; Resendiz-Albor AA; Rosales-Hernández MC
Protein Sci; 2013 Oct; 22(10):1320-35. PubMed ID: 23904252
[TBL] [Abstract][Full Text] [Related]
27. Emodin inhibits aggregation of amyloid-β peptide 1-42 and improves cognitive deficits in Alzheimer's disease transgenic mice.
Wang L; Liu S; Xu J; Watanabe N; Mayo KH; Li J; Li X
J Neurochem; 2021 Jun; 157(6):1992-2007. PubMed ID: 32799401
[TBL] [Abstract][Full Text] [Related]
28. Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber
Tangrodchanapong T; Sornkaew N; Yurasakpong L; Niamnont N; Nantasenamat C; Sobhon P; Meemon K
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920352
[TBL] [Abstract][Full Text] [Related]
29. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
[TBL] [Abstract][Full Text] [Related]
30. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
31. The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.
Ono K; Naiki H; Yamada M
Curr Pharm Des; 2006; 12(33):4357-75. PubMed ID: 17105432
[TBL] [Abstract][Full Text] [Related]
32. Dissecting the Inhibitory Mechanism of the αB-Crystallin Domain against Aβ
Xu Z; Gong Y; Zou Y; Wan J; Tang J; Zhan C; Wei G; Zhang Q
ACS Chem Neurosci; 2022 Oct; 13(19):2842-2851. PubMed ID: 36153964
[TBL] [Abstract][Full Text] [Related]
33. Tolcapone Derivative (Tol-D) Inhibits Aβ42 Fibrillogenesis and Ameliorates Aβ42-Induced Cytotoxicity and Cognitive Impairment.
Chen B; Mou C; Guo F; Sun Q; Qu L; Li L; Cui W; Lu F; Jin C; Liu F
ACS Chem Neurosci; 2022 Mar; 13(5):638-647. PubMed ID: 35148068
[TBL] [Abstract][Full Text] [Related]
34. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
35. Design of carboxylated single-walled carbon nanotubes as highly efficient inhibitors against Aβ40 fibrillation based on the HyBER mechanism.
Zhao W; Jiang L; Wang W; Sang J; Sun Q; Dong Q; Li L; Lu F; Liu F
J Mater Chem B; 2021 Sep; 9(34):6902-6914. PubMed ID: 34612337
[TBL] [Abstract][Full Text] [Related]
36. Biological evaluation of 7-O-amide hesperetin derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
Wu M; Zhu X; Zhang Y; Wang M; Liu T; Han J; Li J; Li Z
Chem Biol Interact; 2021 Jan; 334():109350. PubMed ID: 33307048
[TBL] [Abstract][Full Text] [Related]
37. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
38. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
Ge X; Yang Y; Sun Y; Cao W; Ding F
ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
[TBL] [Abstract][Full Text] [Related]
39. Raloxifene alleviates amyloid-β-induced cytotoxicity in HT22 neuronal cells via inhibiting oligomeric and fibrillar species formation.
Liu Z; Wang Y; Qin W; Chen D; Feng Y; Su H; Shao W; Zhou B; Bu X
J Biochem Mol Toxicol; 2019 Nov; 33(11):e22395. PubMed ID: 31583774
[TBL] [Abstract][Full Text] [Related]
40. Multi-target inhibition ability of neohesperidin dictates its neuroprotective activity: Implication in Alzheimer's disease therapeutics.
Chakraborty S; Rakshit J; Bandyopadhyay J; Basu S
Int J Biol Macromol; 2021 Apr; 176():315-324. PubMed ID: 33581209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
